Get the Stockscreener App
89.19
0.36%
-0.32
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $89.19, with a volume of 12.97M.
It is down -0.36% in the last 24 hours and up +5.95% over the past month.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
See More
Previous Close:
$89.51
Open:
$89.625
24h Volume:
12.97M
Relative Volume:
1.04
Market Cap:
$222.78B
Revenue:
$63.43B
Net Income/Loss:
$16.42B
P/E Ratio:
13.75
EPS:
6.4861
Net Cash Flow:
$14.72B
1W Performance:
+13.53%
1M Performance:
+5.95%
6M Performance:
+3.24%
1Y Performance:
-19.05%
1-Day Range:
$88.10
$90.70
1-Week Range:
$78.03
$91.00
52-Week Range:
$73.31
$111.58
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
89.19 | 223.58B | 63.43B | 16.42B | 14.72B | 6.4861 |
|
LLY
Lilly Eli Co
|
839.87 | 734.96B | 53.26B | 13.80B | -50.20M | 15.08 |
|
JNJ
Johnson Johnson
|
188.64 | 447.90B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
233.91 | 417.90B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
132.39 | 253.54B | 53.40B | 13.68B | 16.89B | 6.8864 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-17-25 | Downgrade | Berenberg | Buy → Hold |
| May-14-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-22-25 | Initiated | Cantor Fitzgerald | Neutral |
| Feb-18-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-10-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-08-25 | Downgrade | Truist | Buy → Hold |
| Dec-20-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-10-24 | Resumed | BofA Securities | Buy |
| Dec-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-11-24 | Downgrade | Daiwa Securities | Buy → Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Oct-20-23 | Upgrade | UBS | Neutral → Buy |
| Jul-14-23 | Initiated | HSBC Securities | Hold |
| Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
| Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-06-23 | Initiated | Jefferies | Buy |
| Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
| Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
| Jun-06-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-17-21 | Initiated | Goldman | Buy |
| Dec-16-21 | Initiated | Daiwa Securities | Neutral |
| Dec-13-21 | Downgrade | UBS | Buy → Neutral |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Upgrade | Argus | Hold → Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-27-21 | Resumed | Truist | Buy |
| May-20-21 | Downgrade | Argus | Buy → Hold |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
| Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-16-19 | Initiated | SVB Leerink | Outperform |
| Jul-03-19 | Initiated | Mizuho | Buy |
| May-28-19 | Initiated | Goldman | Neutral |
| May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-16-18 | Reiterated | Citigroup | Buy |
| Oct-09-18 | Resumed | Guggenheim | Buy |
| Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
| Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
| Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
Bernstein Maintains a Hold Rating on Merck & Co (MRK) - Yahoo Finance
Merck: A Race Against The Keytruda Clock (NYSE:MRK) - Seeking Alpha
Evaxion to present new biomarker data for AI-designed personalized cancer vaccine EVX-01 at the SITC 2025 Annual Meeting - GlobeNewswire Inc.
What Does Wall Street Think About Merck & Co. (MRK)? - MSN
Is Most-Watched Stock Merck & Co., Inc. (MRK) Worth Betting on Now? - Yahoo Finance
Merck & Co (MRK) Announced Positive Results From Phase 3 HYPERION Trial of WINREVAIR - Yahoo Finance
Merck (MRK) Jumps 6.8% on Trump Tariffs, Stellar Pulmonary Hypertension Drug Trial - MSN
Eli Lilly, Merck Surge Among Wednesday’s Market Cap Stock Movers - Investing.com
Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30 - PharmiWeb.com
ABSSSI Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Glenmark Pharma, Melinta Therapeutics, Sandoz Inc, Paratek Pharma, AbbVie Inc., Allergan PLC, Merck & Co. Inc., Pfizer - The Globe and Mail
European healthcare stocks surge as U.S. Pfizer deal reduces some uncertainty - Reuters
Merck & Co. Inc. stock outperforms competitors on strong trading day - MarketWatch
Merck (MRK) Shares Skyrocket, What You Need To Know - Yahoo Finance
Bernstein Maintains a Hold Rating on Merck & Co. (MRK) - Yahoo Finance
Merck’s Keytruda Approval: What’s Next? - StocksToTrade
How Merck & Co. (MRK) Turns Robust Free Cash Flow Into Shareholder Value - Yahoo Finance
Verona Pharma plc (VRNA) Nears $10B Merck Buyout, Ohtuvayre Boosts COPD Portfolio - Yahoo Finance
Merck's Winrevair Cuts Clinical Worsening Risk By 76% Among Hypertension PatientsMerck & Co (NYSE:MRK) - Benzinga
Merck & Co. (MRK) Slid on Weaker Market Sentiment and Concerns About Drug Pipeline - MSN
Bourgeon Capital Management LLC Acquires 10,748 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Union Bancaire Privee UBP SA - MarketBeat
Emerald Advisors LLC Increases Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Mainsail Financial Group LLC Invests $309,000 in Merck & Co., Inc. $MRK - MarketBeat
Park Place Capital Corp Purchases 10,386 Shares of Merck & Co., Inc. $MRK - MarketBeat
Greenleaf Trust Sells 19,620 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by XML Financial LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Capital Investment Advisors LLC - MarketBeat
Sterling Investment Advisors Ltd. Sells 3,254 Shares of Merck & Co., Inc. $MRK - MarketBeat
Janney Montgomery Scott LLC Sells 42,991 Shares of Merck & Co., Inc. $MRK - MarketBeat
GC Wealth Management RIA LLC Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
Avior Wealth Management LLC Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (MRK) Partners with Variational AI to leverage AI in Enhancing Drug Development - Yahoo Finance
With 80% Ownership, Merck & Co., Inc. (NYSE:MRK) Boasts of Strong Institutional Backing - 富途牛牛
Merck (MRK) Announces Positive Recommendation from EU Medicines Agency - MSN
Smith Chas P & Associates PA Cpas Has $28.12 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by FARMERS & MERCHANTS TRUST Co OF LONG BEACH - MarketBeat
Cairn Investment Group Inc. Raises Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by V Square Quantitative Management LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Investment Research & Advisory Group Inc. - MarketBeat
Moody Lynn & Lieberson LLC Decreases Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Company, Inc. (MRK) Stock Analysis: Exploring a 29% Upside Potential and Robust Dividend Yield - DirectorsTalk Interviews
Sonora Investment Management Group LLC Sells 169,105 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (MRK) Advances Oncology Pipeline with Breakthrough FDA Designation for Ovarian Cancer Drug - MSN
Addenda Capital Inc. Has $6.12 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
San Luis Wealth Advisors LLC Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know - sharewise.com
Merck & Co., Inc. $MRK Stake Boosted by Financial Partners Group LLC - MarketBeat
Coastline Trust Co Has $1.72 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Tritonpoint Wealth LLC Trims Stake in Merck & Co., Inc. $MRK - MarketBeat
Fort Washington Investment Advisors Inc. OH Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Stockman Wealth Management Inc. - MarketBeat
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):